Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
Blood|June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoproteinHaiying Qin, Monica Cho, Waleed Haso, et al.
Journal for Immunotherapy of Cancer|November 28, 2020
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemiaGeorge Mo, Hao-Wei Wang, Aimee C Talleur, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
Blood|June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoproteinHaiying Qin, Monica Cho, Waleed Haso, et al.
Journal for Immunotherapy of Cancer|November 28, 2020
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemiaGeorge Mo, Hao-Wei Wang, Aimee C Talleur, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Pageof 13